Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel in adult sickle cell disease
NCT01167023Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2010
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of prasugrel in sickle cell disease (SCD), sponsored by Eli Lilly and Company. Started Jul 2010; status: completed.
02
Drugs
prasugrel
03
Conditions
sickle cell disease (SCD)
Beyond the preview
Go deeper on NCT01167023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01167023.